Founder and CEO of 54gene Selected as Endeavor Entrepreneur

Must Read

- Advertisement -

 Endeavor has welcomed a new entrepreneur into its global network; Dr Abasi Ene-Obong of 54gene was selected as an Endeavor Entrepreneur on September 17, 2020. 54gene is a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. 54gene joins 10 other Endeavor Entrepreneur-led companies in Nigeria, and over 1,300 in Endeavor’s 37 markets across Africa, Latin America, Asia, Europe and North America. 

Founder and CEO of 54gene Selected as Endeavor Entrepreneur
Founder and CEO of 54gene Selected as Endeavor Entrepreneur – www.brandspurng.com

Endeavor is a mission-driven organisation that is leading the global movement for high-impact entrepreneurs and their companies. Endeavor Nigeria selects, mentors and accelerates the best high-impact entrepreneurs in the region, supporting them to scale their companies and drive economic growth. As well as 54gene, this year, Endeavor has welcomed the founders of Daystar PowerMigo and Kobo360 into its local and global network. 

Africa is home to the most genetically diverse population in the world. However, less than 3% of the continent’s genomic data is available for research purposes making it a potentially rich source of new genetic information used for medical discoveries. 54gene is solving this challenge and equalising the access to precision medicine through the advancement of the state of healthcare in Nigeria and on the continent. This is being achieved through local clinical research programs and advanced molecular diagnostics.

“54gene is a critical part of the continent’s push to equalize access to precision medicine for millions of Africans. The rapid pace at which the company has scaled over the past year is testament to Dr. Abasi Ene-Obong’s leadership, his drive and talented team. He is an inspiration to other high-impact entrepreneurs in Nigeria and we are thrilled to welcome him into the Endeavor network.” Said Eloho Omame, Managing Director & CEO of Endeavor in Nigeria.

- Advertisement -

Since launching in 2019, 54gene has scaled its operations in generating novel insights in human genetics research that will lead to high impact health discoveries. At the onset of the COVID-19 pandemic in Nigeria, 54gene raised funds to increase the country’s testing capacity and launched mobile laboratories across 5 Nigerian states. The company has raised $21 million in investment and also launched the African Centre for Translational Genomics (ACTG) to fund the study of Non-Communicable Diseases in 100,000 Nigerians. In September of this year, the company announced a partnership with Illumina to establish a world class genomics facility in Lagos, Nigeria, which will help expand its sequencing-based research and molecular diagnostics offering.  

Dr Abasi Ene-Obong, CEO and Founder of 54gene, said, “It is an absolute honour to be selected as an Endeavor entrepreneur. We started 54gene to significantly improve the inclusion of African populations in global genomics research and I am glad to see our work is being recognised. Our mission is to continue driving innovation and change in research and I look forward to the opportunities that arise as a result of being supported by the global Endeavor network in expanding 54gene’s impact globally.”

Dr Abasi Ene-Obong was successfully selected as part of a cohort of 9 entrepreneurs from 6 markets. With the recent addition of 54gene, Endeavor Nigeria now supports 17 entrepreneurs who lead 11 scale-up stage companies in Nigeria, spanning life sciences, fintech, renewable energy, entertainment, logistics and retail. 

HEADLINES YOU MIGHT HAVE MISSED FROM BRAND SPUR

Lagos Business School Beta Gamma Sigma chapter earns Highest Honours status

Read Also:  Insurance a Necessity: Securing the future, protecting what’s important
- Advertisement -
Read Also:  Arla scales up its commitment to develop a sustainable dairy sector in Nigeria

The Lagos Business School chapter of the Beta Gamma Sigma society has been bestowed the Highest Honours status for the 2019-2020 academic year. The Highest Honours status is the highest distinction possible for Beta Gamma Sigma chapters.

Nestlé to plant 3 million trees by 2023 in Malaysia

Nestlé today announced it will plant three million trees through Project RELeaf in Malaysia. Nestlé will invest CHF 4 million in the next three years. This announcement is part of Nestlé’s broader reforestation initiative. It will help accelerate the company’s global pledge to address climate change and achieve zero net greenhouse gas emissions by 2050.

Nestlé S.A. Increases Stake in Nigeria Subsidiary

- Advertisement -

Nestlé S.A, Switzerland, the parent company of Nestlé Nigeria Plc, has increased its ownership percentage of the Nigerian subsidiary to 66.30 per cent.

Waltersmith Refinery Ready for October Start

Waltersmith Petroman’s modular refinery has been completed and will begin operations on October 14, the Nigerian Content Development and Monitoring Board (NCDMB) has said.

How TikTok Changed Video Advertising Forever?

Owning a business brand isn’t all required to make it big in the business world – it’s just the first step. To achieve business growth, you’d have to invest in activities that improve the quality of your products and services and make potential buyers aware that you have what they need.

- Advertisement -
spot_imgspot_img

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest News

FDA Seeks Public Comments On PMI Application To Market IQOS 3 As Modified Risk Tobacco Product-Brand Spur Nigeria

FDA Seeks Public Comments On PMI Application To Market IQOS 3...

The U.S. Food and Drug Administration (FDA) today opened a public comment period on Philip Morris International’s (PMI--NYSE: PM) application seeking authorization to market the IQOS 3 electrically heated tobacco system...
- Advertisement -
spot_imgspot_img

Latest News

FDA Seeks Public Comments On PMI Application To Market IQOS 3 As Modified Risk Tobacco Product

The U.S. Food and Drug Administration (FDA) today opened a public comment period on Philip Morris International’s (PMI--NYSE: PM) application seeking authorization to...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -spot_imgspot_img